Synthetic Biology for Engineering Applications (R01) (Clinical Trial Optional) | PAR 18 434

Opportunity Information: Apply for PAR 18 434

The Synthetic Biology for Engineering Applications (R01) (Clinical Trial Optional) funding opportunity (PAR 18 434) is a National Institutes of Health (NIH) discretionary grant program that supports research aimed at pushing synthetic biology forward specifically in ways that matter for human health. At its core, the announcement is trying to accelerate both the foundational science and the practical, engineering-driven use of synthetic biology in biomedical contexts. The R01 mechanism signals that NIH is looking for substantial, hypothesis-driven (or well-justified technology-driven) research projects with enough scope and rigor to produce clear advances, not just small pilot efforts.

The FOA emphasizes two main kinds of work. First, it supports the development of novel synthetic biology tools and technologies. That can include building new genetic parts, circuits, control systems, platforms for programmable cell behavior, improved methods for constructing and testing engineered biological systems, and other enabling technologies that make synthetic biology more predictable, scalable, and safe for biomedical use. Second, it supports applying those synthetic biology innovations to biomedical research and human health. In practice, that means taking engineering concepts and synthetic biology methods and using them to answer important biological questions, create new experimental systems, or develop strategies that could ultimately improve prevention, diagnosis, or treatment of disease. The phrase "Clinical Trial Optional" means applicants may propose studies that do not involve clinical trials, but the FOA does not categorically exclude projects that might involve clinical trial components if appropriate and allowable under NIH rules for the chosen approach.

A major theme in this announcement is integration across disciplines. NIH strongly encourages collaborative, team-based proposals where synthetic biologists work closely with computational scientists, cell biologists, engineers, and/or physician scientists. The reason is straightforward: modern synthetic biology for health typically requires computational design and modeling, deep understanding of cellular context, robust engineering and measurement frameworks, and clinically informed problem selection. Proposals that combine these strengths into a single coherent plan are explicitly aligned with the program intent, especially when the collaboration is not superficial but actually shapes the aims, methods, and interpretation of results.

The FOA also makes a point of encouraging Early Stage Investigators in synthetic biology to apply, signaling an interest in bringing new investigators and new ideas into the field. While it remains a competitive NIH R01 program and will expect strong preliminary rationale and a credible plan, the encouragement suggests the program wants to help build capacity and leadership in synthetic biology as it relates to human health.

In terms of eligibility, the opportunity is broad and includes many organization types that NIH commonly supports. Eligible applicants include state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; other Native American tribal organizations; public housing authorities and Indian housing authorities; nonprofits with and without 501(c)(3) status (excluding institutions of higher education where relevant); for-profit organizations (other than small businesses); small businesses; and other applicant types permitted by NIH policy. The FOA also explicitly highlights additional eligible applicant categories, such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and even non-U.S. entities (foreign organizations). That breadth reflects NIH interest in supporting synthetic biology research capacity across a wide range of institutions and communities, including those that are often underrepresented in major biomedical research funding.

Administratively, this is an NIH grant opportunity under the R01 funding instrument, categorized under the Education and Health funding activity areas, and associated with CFDA numbers 93.213, 93.286, and 93.394. The source data lists an original closing date of 2021-01-07 and a creation date of 2017-12-15, which is important because it suggests the specific posting is not newly opened, and applicants would need to confirm whether the FOA is still active, has been reissued, or has been replaced by a newer version before investing heavily in an application.

Overall, the opportunity is aimed at research that treats biology as an engineerable system while staying grounded in biomedical relevance. Strong applications under this FOA would typically (1) present a clear synthetic biology innovation or capability gap, (2) propose a technically credible plan to build or improve a tool, method, or system, (3) demonstrate how that advance will be applied to a meaningful problem in biomedical research or human health, and (4) show real cross-disciplinary integration that strengthens both the engineering and the biological/clinical sides of the project.

• The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Synthetic Biology for Engineering Applications (R01) (Clinical Trial Optional)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.213, 93.286, 93.394.
• This funding opportunity was created on 2017-12-15.
• Applicants must submit their applications by 2021-01-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for PAR 18 434

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: